Direct binding of the MHC class I molecule H-2L(d) to CD8: Interaction with the amino terminus of a mature cell surface protein

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2809-2814

  Jelonek, Marie T ^a   Classon, Brendan J ^b   Hudson, Peter J ^c   Margulies, David H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD8; BINDING SITES; CHO CELLS; CRICETINAE; H-2 ANTIGENS; HUMANS; MEMBRANE PROTEINS; MICE;

EID: 0032520789     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Connolly, J. M., T. A. Potter, E. M. Wormstall, and T. H. Hansen. 1988. The Lyt-2 molecule recognizes residues in the class I α3 domain in allogeneic cytotoxic T cell responses. J. Exp. Med. 168:325.
2. Salter, R. D., A. M. Norment, B. P. Chen, C. Clayberger, A. M. Krensky, D. R. Littman, and P. Parham. 1989. Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8. Nature 338:345.
3. Sanders, S. K., R. O. Fox, and P. Kavathas. 1991. Mutations in CD8 that affect interactions with HLA class 1 and monoclonal anti-CD8 antibodies. J. Exp. Med. 174:371.
4. Leahy, D. J., R. Axel, and W. A. Hendrickson. 1992. Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution. Cell 68: 1145.
5. Giblin, P. A., D. J. Leahy, J. Mennone, and P. B. Kavathas. 1994. The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model. Proc. Natl. Acad. Sci. USA 91:1716.
6. Sun, J., D. J. Leahy, and P. B. Kavathas. 1995. Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the α2 and α3 domains of MHC class I. J. Exp. Med. 182:1275.
7. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
8. Fields, B. A., B. Ober, E. L. Malchiodi, M. I. Lebedeva, B. C. Braden, X. Ysern, J. K. Kim, X. Shao, E. S. Ward, and R. A. Mariuzza. 1995. Crystal structure of the Vα domain of a T cell antigen receptor. Science 270:1821.
9. Konig, R., X. Shen, and R. N. Germain. 1995. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779.
10. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387:630.
11. Salter, R. D., R. J. Benjamin, P. K. Wesley, S. E. Buxton, T. P. Garrett, C. Clayberger, A. M. Krensky, A. M. Norment, D. R. Littman, and P. Parham. 1990. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 345:41.
12. Norment, A. M., R. D. Salter, P. Parham, V. H. Engelhard, and D. R. Littman. 1988. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336:79.
13. Alcover, A., F. Herve, J. P. Boursier, G. Spagnoli, D. Olive, R. A. Mariuzza, and O. Acuto. 1993. A soluble form of the human CD8 alpha chain expressed in the baculovirus system: biochemical characterization and binding to MHC class I. Mol. Immunol. 30:55.
14. Weber, S., and K. Karjalainen. 1993. Mouse CD4 binds MHC class II with extremely low affinity. Int. Immunol. 5:695.
15. Garcia, K. C., C. A. Scott, A. Brunmark, F. R. Carbone, P. A. Peterson, I. A. Wilson, and L. Teyton. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384:577.
16. Corr, M., A. E. Slanetz, L. F. Boyd, M. T. Jelonek, S. Khilko, B. K. al-Ramadi, Y. S. Kim, S. E. Maher, A. L. Bothwell, and D. H. Margulies. 1994. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265:946.
17. Alam, S. M., P. J. Travers, J. L. Wung, W. Nasholds, S. Redpath, S. C. Jameson, and N. R. J. Gascoigne. 1996. T cell receptor affinity and thymocyte positive selection. Nature 381:616.
18. Lyons, D. S., S. A. Lieberman, J. Hampl, J. J. Boniface, Y.-H. Chien, L. J. Berg, and M. M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53.
19. Al-Ramadi, B. K., M. T. Jelonek, L. F. Boyd, D. H. Margulies, and A. L. M. Bothwell. 1995. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the T cell receptor. J. Immunol. 155:662.
20. Luescher, I. F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373:353.
21. b chimeric histocompatibility antigen: purification of soluble protein from transformant cell supematants. Proc. Natl. Acad. Sci. USA 83:5252.
22. d exploits a four residue peptide binding motif. J. Exp. Med. 178:1877.
23. ds: sequence motif, quantitative binding, and molecular modeling of the complex. J. Exp. Med. 176:1681.
24. Khilko, S. N., M. Corr, L. F. Boyd, A. Lees, J. K. Inman, and D. H. Margulies. 1993. Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance: peptide immobilization and characterization of binding specificity. J. Biol. Chem. 268:15425.
25. Margulies, D. H., L. F. Boyd, S. Kozlowski, L. Kjer-Nielsen, R. Lopez, J. Schneck, and R. Hunziker. 1990. Multivalent requirement for the stimulation of alloreactive T cells: studies with engineered soluble MHC class 1 proteins in vitro and in vivo. In Transgenic Mice and Mutants in MHC Research. I. K. Egorov, and C. S. David, eds. Springer-Verlag, Berlin, Heidelberg, p. 39.
26. Schneck, J., W. L. Maloy, J. E. Coligan, and D. H. Margulies. 1989. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell 56:47.
27. Goldstein, J., H. Mostowsky, J. Tung, H. Hon, M. Brunswick, and S. Kozlowski. 1997. Naive alloreactive CD8 T cells are activated by purified major histocompatibility complex class I and antigenic peptide. Eur. J. Immunol. 27.
28. + cytotoxic T lymphocytes by peptide and purified cell-free class I molecules. Int. Immunol. 5:1129.
29. Classon, B. J., M. H. Brown, D. Garnett, C. Somoza, A. N. Barclay, A. C. Willis, and A. F. Williams. 1992. The hinge region of the CD8 alpha chain: structure, antigenicity, and utility in expression of immunoglobulin superfamily domains. Int. Immunol. 4:215.
30. Nakauchi, H., Y. Shinkai, and K. Okumura. 1987. Molecular cloning of Lyt-3, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to immunoglobulin and T cell receptor variable and joining regions. Proc. Natl. Acad. Sci. USA 84:4210.
31. Ledbetter, J. A., and L. A. Herzenberg. 1979. Xonogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.
32. Khilko, S. N., M. T. Jelonek, M. Corr, L. F. Boyd, A. L. Bothwell, and D. H. Margulies. 1995. Measuring interactions of MHC class I molecules using surface plasmon resonance. J. Immunol. Methods 183:77.
33. Chen, W., S. Khilko, J. Fecondo, D. H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471.
34. Del Val, M., H. Volkmer, J. B. Rothbard, S. Jonjic, M. Messerle, J. Schickedanz, M. J. Reddehase, and U. H. Koszinowski. 1988. Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J. Virol. 62:3965.
35. + T-cell clone. Proc. Natl. Acad. Sci. USA 90:11272.
36. Sykulev, Y., A. Brunmark, T. J. Tsomides, S. Kageyama, M. Jackson, P. A. Peterson, and H. N. Eisen. 1994. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91:11487.
37. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An α/β T cell receptor structure at 2 5Å and its orientation in the TCR-MHC complex. Science 274:209.
38. Garboczi, D. N., P. Ghosh, U. Utz, Q. R Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
39. Padlan, E. A., and D. H. Margulies. 1997. Immunology: feeling out the receptor. Curr. Biol. 7:R17.
40. Saper, M. A., P. J. Bjorkman, and D. C. Wiley. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219:277.
41. Collins, E. J., D. N. Garboczi, and D. C. Wiley. 1994. Three-dimensional structure of a peptide extending from one end of a class I MHC binding sue. Nature 371:626.
42. b) associated with unusually long peptides: implications for antigen processing and presentation. Proc. Natl. Acad. Sci. USA 91:4145.
43. Chvatchko, Y., E. Van Obberghen, N. Kiger, and M. Fehlmann. 1983. Immunoprecipitation of insulin receptors by antibodies against class I antigens of the murine H-2 major histocompatibility complex. FEBS Lett. 163:207.
44. Fehlmann, M., J. F. Peyron, M. Samson, E. Van Obberghen, D. Brandenburg, and N. Brossette. 1985. Molecular association between major histocompatibility complex class I antigens and insulin receptors in mouse liver membranes. Proc. Natl. Acad. Sci. USA 82:8634.
45. Due, C., M. Simonsen, and L. Olsson. 1986. The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens. Proc. Natl. Acad. Sci. USA 83:6007.
46. Phillips, M. L., M. L. Moule, T. L. Delovitch, and C. C. Yip. 1986. Class I histocompatibility antigens and insulin receptors: evidence for interactions. Proc. Natl. Acad. Sci. USA 83:3474.
47. Verland, S., M. Simonsen, S. Gammeltoft, H. Allen, R. A. Flavell, and L. Olsson. 1989. Specific molecular interaction between the insulin receptor and a D product of MHC class I. J. Immunol. 143:945.
48. Edidin, M., and J. Reiland. 1990. Dynamic measurements of the associations between class I MHC antigens and insulin receptors. Mol. Immunol. 27:1313.
49. Reiland, J., and M. Edidin. 1993. Chemical cross-linking detects association of insulin receptors with four different class I human leukocyte antigen molecules on cell surfaces. Diabetes 42:619.
50. Blue, M. L., K. A. Craig, P. Anderson, K. R. Branton, Jr., and S. F. Schlossman. 1988. Evidence for specific association between class I major histocompatibility genes and the CD8 molecules of human suppressor/cytotoxic cells. Cell 29:413.
51. Sharon, M., R. D. Klausner, B. R. Cullen, R. Chizzonite, and W. J. Leonard. 1986. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science 234:859.
52. Solano, A. R., M. L. Sanchez, M. L. Sardanons, L. Dada, and E. J. Podesta. 1988. Luteinizing hormone triggers a molecular association between its receptor and the major histocompatibility complex class I antigen to produce cell activation. Endocrinology 122:2080.
53. Solano, A. R., G. Cremaschi, M. L. Sanchez, E. Borda, L. Sterin-Borda, and E. J. Podesta. 1988. Molecular and biological interaction between major histocompatibility complex class I antigens and luteinizing hormone receptors or beta-adrenergic receptors triggers cellular response in mice. Proc. Natl. Acad. Sci. USA 85:5087.
54. Frohman, E. M., B. Vayuvegula, S. Gupta, and S. van den Noort. 1988. Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via β-2-adrenergic signal transduction mechanisms. Proc. Natl. Acad. Sci. USA 85:1292.
55. Cremaschi, G. A., S. Miguel, C. Cazaux, and L. Sterin-Borda. 1994. Increased proliferative activity, loss of beta-adrenergic receptor function and class I major histocompatibility complex antigen surface expression in a modified lymphoma cell line. Cell. Signal. 6:781.
56. Schreiber, A. B., J. Schlessinger, and M. Edidin. 1984. Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells. J. Cell Biol. 98:725.
57. Cremaschi, G. A., and L. Sterin-Borda. 1994. MHC class I-hormone receptor associations: still a physiological enigma? Acta Physiol. Pharmacol. Ther. Latinoam. 44:55.
58. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163.
59. Cresswell, P., M. J. Androlewicz, and B. Ortmann. 1994. Assembly and transport of class I MHC-peptide complexes. Ciba Found. Symp. 187:150.
60. Jackson, M. R., M. F. Cohen-Doyle, P. A. Peterson, and D. B. Williams. 1994. Regulation of MHC class I transport by the molecular chaperone. calnexin (p88, IP90). Science 263:384.
61. Carreno, B. M., J. C. Solheim, M. Harris, I. Stroynowski, J. M. Connolly, and T. H. Hansen. 1995. TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man. J. Immunol. 155:4726.
62. Ware, F. E., A. Vassilakos, P. A. Peterson, M. R. Jackson, M. A. Lehrman, and D. B. Williams. 1995. The molecular chaperone calnexin binds Glc1 Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. J. Biol. Chem. 270:4697.
63. Ora, A., and A. Helenius. 1995. Calnexin fails to associate with substrate proteins in glucosidase-deficient cell lines. J. Biol. Chem. 270:26060.
64. Vassilakos, A., M. F. Cohen-Doyle, P. A. Peterson, M. R. Jackson, and D. B. Williams. 1996. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J. 15:1495.
65. Suh, W. K., E. K. Mitchell, Y. Yang, P. A. Peterson, G. L. Waneck, and D. B. Williams 1996. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J. Exp. Med. 184:337.
66. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103.
67. Solheim, J. C., B. M. Carreno, and T. H. Hansen. 1997. Are transporter associated with antigen processing (TAP) and tapasin class I MHC chaperones? J. Immunol. 158:541.